Hbk Investments L P Bristol Myers Squibb CO Call Options Transaction History

Hbk Investments L P

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $26.5 Million - $29.4 Million	-415,200 Reduced 96.81%	13,700 $876,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $1.89 Million - $2.14 Million	-28,700 Reduced 6.27%	428,900 $29.7 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $26.3 Million - $31.1 Million	383,800 Added 520.05%	457,600 $32.9 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $8,294 - $4.9 Million	63,800 Added 638.0%	73,800 $5.25 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $726,200 - $799,800	10,000 New	10,000 $770,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.